RNPS1 functions as an oncogenic splicing factor in cervical cancer cells

Numerous recent studies suggest that cancer‐specific splicing alteration is a critical contributor to the pathogenesis of cancer. RNA‐binding protein with serine‐rich domain 1, RNPS1, is an essential regulator of the splicing process. However, the defined role of RNPS1 in tumorigenesis still remains elusive. We report here that the expression of RNPS1 is higher in cervical carcinoma samples from The Cancer Genome Atlas (TCGA‐cervical squamous cell carcinoma and endocervical adenocarcinoma) compared to the normal tissues. Consistently, the expression of RNPS1 was high in cervical cancer cells compared to a normal cell line. This study shows for the first time that RNPS1 promotes cell proliferation and colony‐forming ability of cervical cancer cells. Importantly, RNPS1 positively regulates migration‐invasion of cervical cancer cells. Intriguingly, depletion of RNPS1 increases the chemosensitivity against the chemotherapeutic drug doxorubicin in cervical cancer cells. Further, we characterized the genome‐wide isoform switching stimulated by RNPS1 in cervical cancer cell. Mechanistically, RNA‐sequencing analysis showed that RNPS1 regulates the generation of tumor‐associated isoforms of key genes, particularly Rac1b, RhoA, MDM4, and WDR1, through alternative splicing. RNPS1 regulates the splicing of Rac1 pre‐mRNA via a specific alternative splicing switch and promotes the formation of its tumorigenic splice variant, Rac1b. While the transcriptional regulation of RhoA has been well studied, the role of alternative splicing in RhoA upregulation in cancer cells is largely unknown. Here, we have shown that the knockdown of RNPS1 in cervical cancer cells leads to the skipping of exons encoding the RAS domain of RhoA, consequently causing decreased expression of RhoA. Collectively, we conclude that the gain of RNPS1 expression may be associated with tumor progression in cervical carcinoma. RNPS1‐mediated alternative splicing favors an active Rac1b/RhoA signaling axis that could contribute to cervical cancer cell invasion and metastasis. Thus, our work unveils a novel role of RNPS1 in the development of cervical cancer.

[1]  Yasamin Hamza Sharif,et al.  Clinical correlation of cervical cancer screening using Pap smear test. , 2022, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique.

[2]  Y. Kang,et al.  RNA-binding protein with serine-rich domain 1 regulates microsatellite instability of uterine corpus endometrial adenocarcinoma , 2021, Clinics.

[3]  M. Laddad,et al.  PAP smear versus colposcopy in symptomatic women and women with suspicious-looking cervix , 2021 .

[4]  K. Kyriakopoulou,et al.  Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer , 2021, Cancers.

[5]  A. Chatziioannou,et al.  Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency , 2021, Genes.

[6]  J. Scarth,et al.  E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer , 2020, Cell Death & Differentiation.

[7]  E. Goka,et al.  Rac1b: An emerging therapeutic target for chemoresistance in colorectal cancer , 2020, Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies.

[8]  M. E. Alvarez-Sánchez,et al.  Role of Matrix Metalloproteinases in Angiogenesis and Cancer , 2019, Front. Oncol..

[9]  Jacques Ferlay,et al.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.

[10]  Cynae A. Johnson,et al.  Cervical Cancer: An Overview of Pathophysiology and Management. , 2019, Seminars in oncology nursing.

[11]  H. Lehnert,et al.  RAC1B: A Rho GTPase with Versatile Functions in Malignant Transformation and Tumor Progression , 2019, Cells.

[12]  J. Grandis,et al.  The JNK Pathway in Drug Resistance , 2019, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy.

[13]  Christoph Dieterich,et al.  Exon Junction Complexes Suppress Spurious Splice Sites to Safeguard Transcriptome Integrity. , 2018, Molecular cell.

[14]  Steven J. M. Jones,et al.  Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients , 2018, Cancer cell.

[15]  Chao Yang,et al.  WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer through ADF/cofilin-mediated Actin Dynamics , 2018, International journal of biological sciences.

[16]  Kunio Inoue,et al.  Splicing activator RNPS1 suppresses errors in pre-mRNA splicing: A key factor for mRNA quality control. , 2018, Biochemical and biophysical research communications.

[17]  A. Ridley,et al.  Rho GTPase signaling complexes in cell migration and invasion , 2018, The Journal of cell biology.

[18]  D. Barford,et al.  Visualizing the complex functions and mechanisms of the anaphase promoting complex/cyclosome (APC/C) , 2017, Open Biology.

[19]  F. Toledo,et al.  Targeting MDM4 Splicing in Cancers , 2017, Genes.

[20]  N. Cho,et al.  STAT3-induced WDR1 overexpression promotes breast cancer cell migration. , 2016, Cellular signalling.

[21]  K. Nakai,et al.  The Exon Junction Complex Controls the Efficient and Faithful Splicing of a Subset of Transcripts Involved in Mitotic Cell-Cycle Progression , 2016, International journal of molecular sciences.

[22]  R. Campbell,et al.  Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. , 2016, The Journal of clinical investigation.

[23]  Xiaolong He,et al.  Regulation and functional significance of CDC42 alternative splicing in ovarian cancer , 2015, Oncotarget.

[24]  Hubing Shi,et al.  MDM4 is a key therapeutic target in cutaneous melanoma , 2012, Nature Medicine.

[25]  D. Radisky,et al.  Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression , 2012, Science Translational Medicine.

[26]  Sherif Abou Elela,et al.  Proteins Associated with the Exon Junction Complex Also Control the Alternative Splicing of Apoptotic Regulators , 2011, Molecular and Cellular Biology.

[27]  Gaëlle A.V. Boulet Molecular markers in cervical cancer screening , 2010 .

[28]  Yan Cheng,et al.  Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. , 2009, Cancer letters.

[29]  H. Urlaub,et al.  Isolation of an active step I spliceosome and composition of its RNP core , 2008, Nature.

[30]  E. Sakashita,et al.  Activation of Pre-mRNA Splicing by Human RNPS1 Is Regulated by CK2 Phosphorylation , 2005, Molecular and Cellular Biology.

[31]  E. Lengyel,et al.  Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation , 2004, Oncogene.

[32]  Radovan Dvorsky,et al.  Alternative Splicing of Rac1 Generates Rac1b, a Self-activating GTPase* , 2004, Journal of Biological Chemistry.

[33]  S. Ono Regulation of actin filament dynamics by actin depolymerizing factor/cofilin and actin-interacting protein 1: new blades for twisted filaments. , 2003, Biochemistry.

[34]  D. Reinberg,et al.  ASAP, a Novel Protein Complex Involved in RNA Processing and Apoptosis , 2003, Molecular and Cellular Biology.

[35]  D. Sgroi,et al.  Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. , 2002, Genes & development.

[36]  A. Ridley Rho GTPases and cell migration. , 2001, Journal of cell science.

[37]  E. Lengyel,et al.  Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b , 2000, Oncogene.

[38]  Michael Q. Zhang,et al.  Purification and characterization of human RNPS1: a general activator of pre‐mRNA splicing , 1999, The EMBO journal.

[39]  G. Fiucci,et al.  Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. , 1995, Journal of immunology.

[40]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[41]  L. G. Koss,et al.  Cervical Cancer , 1981, Current Topics in Pathology.